4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-009440
Director sold 503 shares at $64.05 ($32,217)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Jeffrey William Director | 2025-04-01 | Sale 10b5-1 | −503 | $64.05 | $32,217 | 33,108 | D |
| Open-market sales · 503 sh · avg $64.05 · $32,217 | |||||||
Loading xslF345X05/form4-04012025_100413.xml…